{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:06:01Z","timestamp":1789909561650,"version":"4.0.1"},"reference-count":26,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,11,9]],"date-time":"2009-11-09T00:00:00Z","timestamp":1257724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Photoderm Photoimm Photomed"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:p><jats:bold>Objectives: <\/jats:bold> To determine the safety and efficacy of photodynamic therapy (PDT) with topical application of 20%\u2003wt\/vol aminolevulinic acid hydrochloride (ALA) in the treatment of condylomata acuminata (CA).<\/jats:p><jats:p><jats:bold>Study design: <\/jats:bold> Patients with CA were randomly allocated into the ALA\u2010PDT group and the CO<jats:sub>2<\/jats:sub> laser group in an allocation ratio of 3\u2003:\u20031. The treatment was repeated weekly if necessary, but no more than 3 times. The primary efficacy endpoint was the wart clearance rate 1 week after the last treatment. The recurrence rate was evaluated at weeks 4, 8 and 12 after the treatment ended. The clinical response to therapy and adverse effects were recorded.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> A total of 91 patients with CA were enrolled in the clinical trial. Of these 90 (98.9%) patients completed the trial (67 in the ALA\u2010PDT group, and 23 in CO<jats:sub>2<\/jats:sub> laser group). By 1 week after the last treatment, the complete clearance rate was 95.93% in the ALA\u2010PDT group and 100% in CO<jats:sub>2<\/jats:sub> laser group (<jats:italic>P<\/jats:italic>&gt;0.05). The clearance rate of CA at male urethral orifice was100% in the ALA\u2010PDT group and 100% in the CO<jats:sub>2<\/jats:sub> laser group (<jats:italic>P<\/jats:italic>&gt;0.05). The overall recurrence rate calculated by the end of the entire follow\u2010up period was significantly lower in the ALA\u2010PDT group than that in the CO<jats:sub>2<\/jats:sub> laser group (9.38% vs 17.39%, <jats:italic>P<\/jats:italic>&lt;0.05). Moreover, there was no systemic adverse event in either group. The proportion of patients with adverse effects in the ALA\u2010PDT group (8.82%) was also significantly lower than that in the CO<jats:sub>2<\/jats:sub> laser group (100%, <jats:italic>P<\/jats:italic>&lt;0.05). The side\u2010effects in patients treated with ALA\u2010PDT mainly included mild burning and\/or stinging restricted to the illuminated area.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold> The results confirmed that topical application of ALA\u2010PDT is a simpler and as effective therapy with a lower incidence of adverse effects in the treatment of CA compared with conventional CO<jats:sub>2<\/jats:sub> laser therapy.<\/jats:p>","DOI":"10.1111\/j.1600-0781.2009.00467.x","type":"journal-article","created":{"date-parts":[[2009,11,10]],"date-time":"2009-11-10T15:39:39Z","timestamp":1257867579000},"page":"293-297","source":"Crossref","is-referenced-by-count":53,"title":["Evaluation of photodynamic therapy using topical aminolevulinic acid hydrochloride in the treatment of condylomata acuminata: a comparative, randomized clinical trial"],"prefix":"10.1111","volume":"25","author":[{"given":"Jun","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Nian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,11,9]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042307-200201000-00011"},{"key":"e_1_2_6_3_2","first-page":"143","article-title":"Photodynamic therapy with endogenous protoporphyrin IX","volume":"6","author":"Kennedy JC","year":"1990","journal-title":"basic principles and present clinical experience"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200001020-00009"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/1011-1344(92)85108-7"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70002-B"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1996.d01-1076.x"},{"key":"e_1_2_6_8_2","first-page":"43","article-title":"Topical 5\u2010aminolevulinic acid for the photodynamic therapy of psoriasis and actinic keratoses","volume":"7","author":"Nelson JS","year":"1995","journal-title":"Lasers Surg Med Suppl"},{"key":"e_1_2_6_9_2","first-page":"963","article-title":"Photodynamic therapy with 5\u2010aminolaevulinic acid or placebo for recalcitrant foot and hand warts","volume":"355","author":"Stender IM","year":"2000","journal-title":"randomised double-blind trial"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.9.1093"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.10048"},{"key":"e_1_2_6_12_2","first-page":"320","article-title":"Photodynamic therapy of benign viral vulvar lesions","volume":"67","author":"Uhlir M","year":"2002","journal-title":"Ceska Gynekol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2003.05553.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06189.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2005.01935.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07648.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2007.06352.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(03)00083-X"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.1.116"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-04511-4_11"},{"key":"e_1_2_6_21_2","first-page":"736","article-title":"Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5\u2010aminolaevulinic acid","volume":"5","author":"Ross EV","year":"1997","journal-title":"implicationsfor photodynamic treatment"},{"key":"e_1_2_6_22_2","first-page":"121","article-title":"Fluorescence urethroscopy following instillation of 5\u2010aminolevulinic acid","volume":"15","author":"Schneede P","year":"2000","journal-title":"a new procedure for detecting clinical and subclinical HPV lesions of the urethra"},{"key":"e_1_2_6_23_2","first-page":"1","article-title":"The role of apoptosis in response to photodynamic therapy","volume":"1","author":"Oleinick NL","year":"2002","journal-title":"what, where, why and how"},{"key":"e_1_2_6_24_2","first-page":"129","article-title":"Viral inactivation in blood and red cell concentrations with benzoporphyrin derivative","volume":"18","author":"North J","year":"1992","journal-title":"Blood Cells"},{"key":"e_1_2_6_25_2","first-page":"736","article-title":"Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5\u2010aminolaevulinic acid","volume":"137","author":"Ross EV","year":"1997","journal-title":"implications for photodynamic treatment"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)40138-8"},{"key":"e_1_2_6_27_2","first-page":"340","article-title":"Photodynamic therapy in dermatology","volume":"16","author":"Babilas P","year":"2006","journal-title":"Eur J Dermatol"}],"container-title":["Photodermatology, Photoimmunology &amp; Photomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0781.2009.00467.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0781.2009.00467.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T02:58:19Z","timestamp":1696993099000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0781.2009.00467.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,9]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["10.1111\/j.1600-0781.2009.00467.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0781.2009.00467.x","archive":["Portico"],"relation":{},"ISSN":["0905-4383","1600-0781"],"issn-type":[{"value":"0905-4383","type":"print"},{"value":"1600-0781","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,9]]}}}